期刊文献+

RNA干扰CD36表达对潜在转化生长因子-β1活化和矽肺纤维化的抑制 被引量:1

The inhibitory effect of lantent transforming growth factor activation and silicosis by CD36 targeted RNA interference in silicosis model of rat
原文传递
导出
摘要 目的观察大鼠矽肺模型中RNA干扰CD36基因表达对潜在转化生长因子-β1(L—TGF—B.)的活化及矽肺纤维化的抑制作用。方法将Wistar大鼠分为生理盐水组、SiO2模型组(10mgSiO2)、CD36shRNA表达的重组慢病毒(Si02+IJv—shCD36)组和对照慢病毒(SiO2+Lv—shCD36一NC)组,每组24只。染尘后7、21、28d处死动物,貂肺上皮细胞增殖抑制实验检测肺泡灌洗液(BALF)中转化生长因子一B,(TGF—p。)的活性;HE和VG染色观察肺组织病理变化;碱裂解法测定肺羟脯氨酸含量。结果染尘7d时,SiO,+Lv—shCD36组大鼠肺泡巨噬细胞CD36mRNA的表达明显低于生理盐水组、SiO2模型组和SiO2+lJv—shCD36一NC组,差异有统计学意义(p〈O.05)。SiO2+Lv.shCD36组大鼠BALF中TGF.13.活化量和活化率均明显低于模型组和SiO2+lJv—shCD36一NC组,差异有统计学意义(P〈0.05)。染尘28d时,SiO2+Lv—shCD36组大鼠肺组织可见细胞性矽结节,而模型组和SiO2+Lv—shCD36-NC组大鼠肺组织可见纤维细胞性矽结节。染尘21d和28d时,SiO2+Lv—shCD36组大鼠肺羟脯氨酸含量明显低于SiO2模型组和SiO,+Lv—shCD36-NC组,差异有统计学意义(P〈0.05)。结论大鼠矽肺模型中通过RNA干扰CD36基因表达能够对L—TGF—B,的活化和矽肺纤维化具有一定的抑制作用。 Objective To investigate the inhibitory effects of CD36-targeting RNA interference on the latent transforming growth factorβ1 (L-TGF-β1) activation and silicotic fibrosis in rat silicosis model. Methods Wistar rats were divided into four groups: saline control group (n=24), SiO2 model group (10 mg SiO2 per rat) (n=24), SiO2+Lv-shCD36 group (lentiviral vector expressing specific shRNA against CD36) (n=24), and SiO2+Lv-shCD36-NC group (non-silence control lentivirus) (n=24). At 7, 21, and 28 d after instillation, therats were sacrificed. The activity of TGF-β1 in bronchoalveolar lavage fluid (BALF) was measured by evaluating its inhibitory effect on the proliferation of mink lung epithelial cells. The pathological changes of lung tissue were observed by HE staining and van Gieson staining. The hydroxyproline content in the lungs was determined by alkaline lysis method. Results At 7 d after instillation, the expression of CD36 mRNA in alveolar macrophages was significantly lower in the SiO2+Lv-shCD36 group than in the saline control group, Si02 model group, and SiO2+Lv-shCD36-NC group (P〈0.05); the quantity and percentage of active TGF-β1 in BALF were significantly lower in the SiO2+Lv-shCD36 group than in the SiO2 model group and SiO2+Lv-shCD36-NC group (P〈0.05). At 28 d after instillation, there were cellular silicotic nodules in the lungs of rats in SiO2+Lv-shCD36 group and fibrotic cellular silicotic nodules in the lungs of rats in SiO2 model group and SiO2+Lv-shCD36-NC group. At 21 and 28 d after instillation, the hydroxyproline content was significantly lower in the SiO2 +Lv- shCD36 group than in the SiO2 model group and SiO2+Lv-shCD36-NC group (P〈0.05). Conclusion CD36-targeting RNA interference has inhibitory effects on the L-TGF-βactivation and silicotic fibrosis in rat silicosis model.
出处 《中华劳动卫生职业病杂志》 CAS CSCD 北大核心 2013年第7期518-521,共4页 Chinese Journal of Industrial Hygiene and Occupational Diseases
基金 国家自然科学基金资助项目(81102106)
关键词 矽肺 抗原 CD36 转化生长因子Β1 纤维化 Silicosis Antigens, CD36 Transforming growth factor-beta Pulmonary fibrosis
  • 相关文献

参考文献10

  • 1Usuki J, Matsuda K, Azuma A, et al. Sequential analysis of myofibroblast differentiation and transforming growth factor-J31/ Smad pathway activation in murine pulmonary fibrosis. J Nippon Med Sch, 2012, 79:46-59.
  • 2Liu L, Lu W, Ma Z, et al. Oxymatrine attenuates bleomycin-induced? pulmonary fibrosis?in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-I/Smad signaling pathway. Int J Mol Med, 2012,29:815-822.
  • 3Ye H, Cai PC, Zhou Q, et al. Transforming growth faetor-13 suppresses the up-regulation of matrix metalloproteinase-2 by lung fibroblasts in response to tumor necrosis?factor-eL. Wound Repair Regen, 2011, 19:392-399.
  • 4Rosenbloom J, Jim6nez SA. Molecular ablation of transforming growth factor beta signaling pathways by tyrosine kinase inhibition: the coming of a promising new era in the treatment of tissue fibrosis. Arthritis Rheum, 2008, 58: 2219-2224.
  • 5Yang YL, Lin SH, Chuang LY, et al. CD36 is a novel and potential anti-fibrogenic target in albumin-induced renal proximal tubule fibrosis. J Cell Biochem, 2007, 101: 735-744.
  • 6Yehualaeshet T, O'Connor R, Green-Johnson J, et al. Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am J Pathol, 1999, 155: 841-851.
  • 7缪荣明,张雪涛,严于兰,何恩奇,郭平,张颖轶,赵道昆,杨志刚,陈洁,姚明莺,赵锐,房中华,姚雍铭.矽肺患者血清转化生长因子-β1和肿瘤坏死因子-α的变化[J].中华劳动卫生职业病杂志,2011,29(8):606-607. 被引量:16
  • 8Bonniaud P, Margetts PJ, Ask K, et al. TGF-beta and Smad3 signaling link inflammation to chronicfibrogenesis. J Immunol,2005, 175:5390-5395.
  • 9Xu YD, Hua J, Mui A, et al. Release of biologically active TGF- betal by alveolar epithelial cells results in pulmonal7 fibrosis. Am J Physiol Lung Cell MolPhysiol,2003,285:L527-39.
  • 10陈莹,王欣,翁东,陶莎莎,吕丽娜,田璐佳,陈杰.血小板反应素-1的Ⅰ型重复序列功能肽段对小鼠肺纤维化的抑制作用[J].中华劳动卫生职业病杂志,2009,27(1):45-47. 被引量:1

二级参考文献16

  • 1Cutroneo KR,White SL,Phan SH,et al. Therapies for bleomycin induced lung fibrosis through regulation of TGF-betal induced collagen gene expression. J Cell Physiol, 2007,211:585-589.
  • 2Xu Q, Norman JT, Shrivastav S, et al. In vitro models of TGF-beta- induced fibrosis suitable for high-throughput screening of antifibrotic agents. Am J Physiol Renal Physiol, 2007,293 : 631- 640.
  • 3Xaubet A, Marin-Arguedas A, Lario S,et al. Transforming growth factor-betal gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2003,168 : 431-435.
  • 4Chen Y,Chen J,Dong J,et al. Antifibrotie effect of interferon gamma in silicosis model of rat. Toxicol Lett, 2005,155:353-360.
  • 5Daniel C,Wiede J,Krutzsch HC,et al. Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo. Kidney Int, 2004,65 : 459-468.
  • 6Ribeiro SM, Poczatek M, Schultz CS, et al. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem, 1999,274: 13586-13593.
  • 7Bonniaud P,Margetts PJ,Ask K,et al. TGF-beta and Smad3 signaling link inflammation to chronicfibrogenesis. J Immunol, 2005,175 : 5390-5395.
  • 8Xu YD, Hua J, Mui A,et al. Release of biologically active TGF- betal by alveolar epithelial cells results in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol, 2003,285 : 527-539.
  • 9Khalil N. Post translational activation of latent transforming growth factor beta( L-TGF-beta ) : clinical implications. Histol Histopathol, 2001,16:541-551.
  • 10Brown T. Silica exposure, smoking, silicosis and lung cancer-complex interactions. Occup Med (Lond), 2009, 59: 89-95.

共引文献15

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部